Therefore, the aim of current study was to investigate the antitumor and pro-immunogenic properties of ADI-PEG 20 on ASS1-deficient MC38 and MDA-MB-231 cancer cells (Figure 2A) in vitro. The gene discussed is ASS1; the disease is cancer.